

NCT02816762 Raw comparison:

Summary:
CHIA has 16 criteria while your personal folder has 18 criteria
Total found criteria: 16/16
Total not Found: 0/16
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Subjects aged 18 to 80 years old                   │ Subjects aged 18 to 80 years old                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Overweight or obesity (BMI =25 kg/m2)              │ Overweight or obesity (BMI ≥25 kg/m2)              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous diagnosis of type 2 diabetes fulfilling   │ Previous diagnosis of type 2 diabetes fulfilling   │
│ at least one of the following criteria 1) current  │ at least one of the following criteria 1) current  │
│ treatment with oral antidiabetic drugs and/or      │ treatment with oral antidiabetic drugs and/or      │
│ insulin 2) a fasting glucose value above 126 mg/dl │ insulin 2) a fasting glucose value above 126 mg/dl │
│ on at least 2 occasions 3) blood glucose level at  │ on at least 2 occasions 3) blood glucose level at  │
│ 2 hours after an oral glucose tolerance test is    │ 2 hours after an oral glucose tolerance test is    │
│ equal to or more than 200 mg/dl or 4) a glycated   │ equal to or more than 200 mg/dl or 4) a glycated   │
│ hemoglobin (HbA1c) level > 6 5 %                   │ hemoglobin (HbA1c) level \> 6 5 %                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Clinical diagnosis of diabetic nephropathy with a  │ Clinical diagnosis of diabetic nephropathy with a  │
│ urinary albumin/creatinine ratio >30 mg/g and an   │ urinary albumin/creatinine ratio \>30 mg/g and an  │
│ estimated glomerular filtration rate more than 20  │ estimated glomerular filtration rate more than 20  │
│ ml/min per 1 73 m2                                 │ ml/min per 1 73 m2                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Treatment with stable doses of angiotensin-        │ Treatment with stable doses of angiotensin-        │
│ converting enzyme inhibitors angiotensin II        │ converting enzyme inhibitors angiotensin II        │
│ receptor blockers or anti-aldosterone agents in    │ receptor blockers or anti-aldosterone agents in    │
│ the last four weeks                                │ the last four weeks                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Non diabetic nephropathy (confirmed by biopsy)     │ Non diabetic nephropathy (confirmed by biopsy)     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Dialysis for acute renal failure within the 6      │ Dialysis for acute renal failure within the 6      │
│ previous months                                    │ previous months                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Evidence in the clinic history of relevant         │ Evidence in the clinic history of relevant         │
│ bilateral stenosis of renal artery (> 75%)         │ bilateral stenosis of renal artery (\> 75%)        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Urinary albumin/creatinine ratio higher than 3000  │ Urinary albumin/creatinine ratio higher than 3000  │
│ mg/g at the baseline visit                         │ mg/g at the baseline visit                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Systolic blood pressure = 180 mmHg or diastolic    │ Systolic blood pressure ≥ 180 mmHg or diastolic    │
│ blood pressure = 110 mm Hg at the baseline visit   │ blood pressure ≥ 110 mm Hg at the baseline visit   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Stroke transient ischemic attack acute coronary    │ Stroke transient ischemic attack acute coronary    │
│ syndrome or hospitalization for heart failure      │ syndrome or hospitalization for heart failure      │
│ worsening within the previous 30 days              │ worsening within the previous 30 days              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Professional drivers risk profession or            │ Professional drivers risk profession or            │
│ respiratory failure                                │ respiratory failure                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe daytime sleepiness (Epworth sleepiness      │ Severe daytime sleepiness (Epworth sleepiness      │
│ scale >18)                                         │ scale \>18)                                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Concomitant treatment with high doses of           │ Concomitant treatment with high doses of           │
│ acetylsalicylic acid (> 500 mg/day) or continuous  │ acetylsalicylic acid (\> 500 mg/day) or continuous │
│ treatment with non-steroidal anti-inflammatory     │ treatment with non-steroidal anti-inflammatory     │
│ drugs                                              │ drugs                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous treatment with CPAP                       │ Previous treatment with CPAP                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Participation in another clinical trial within the │ Participation in another clinical trial within the │
│ 30 days prior to randomization                     │ 30 days prior to randomization                     │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have maximum age of 80 Years │
├───────────────────────────────────┤
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛